Not a recommended buy for the short term. However, this company has shown tremendous growth over the past years, and it will be interesting to see how a change in the economy will affect this company's earnings.(Dare I predict a correction in the market?) RemedyTemps's services are important to even the smallest companies. REMX is a great indicator for its industry of staffing, and more specifically temorary staffing. Still not a recommended buy, as it has shown a progressive decrease in value over the past month. Best of luck.Bryan M. MatteiMattei999@aol.com
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings